Cyclophilin A secreted from fibroblast-like synoviocytes is involved in the induction of CD147 expression in macrophages of mice with collagen-induced arthritis
© Nishioku et al.; licensee BioMed Central Ltd. 2012
Received: 22 June 2012
Accepted: 10 November 2012
Published: 20 November 2012
Cyclophilin A (CypA), a member of the immunophilin family, is a ubiquitously distributed intracellular protein. Recent studies have shown that CypA is secreted by cells in response to inflammatory stimuli. Elevated levels of extracellular CypA and its receptor, CD147 have been detected in the synovium of patients with RA. However, the precise process of interaction between CypA and CD147 in the development of RA remains unclear. This study aimed to investigate CypA secretion from fibroblast-like synoviocytes (FLS) isolated from mice with collagen-induced arthritis (CIA) and CypA-induced CD147 expression in mouse macrophages.
CIA was induced by immunization with type II collagen in mice. The expression and localization of CypA and CD147 was investigated by immunoblotting and immunostaining. Both CypA and CD147 were highly expressed in the joints of CIA mice. CD147 was expressed in the infiltrated macrophages in the synovium of CIA mice. In vitro, spontaneous CypA secretion from FLS was detected and this secretion was increased by stimulation with lipopolysaccharide. CypA markedly increased CD147 levels in macrophages.
These findings suggest that an interaction in the synovial joints between extracellular CypA and CD147 expressed by macrophages may be involved in the mechanisms underlying the development of arthritis.
KeywordsCD147 Collagen-induced arthritis Cyclophilin A Macrophage Rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized by synovial hyperplasia and articular cartilage degradation. The hyperplasia of the synovial lining is largely composed of increased number of fibroblast-like synoviocytes (FLS) and macrophages. FLS play a critical role in RA pathogenesis by inducing the inflammatory microenvironment in the synovial joints through production of pro-inflammatory factors or recruitment of other immune cells. Macrophages are localized in the synovial lining with FLS, where they modulate the function of each other through surface molecules as well as soluble mediators .
Cyclophilin A (CypA), the most abundant cytoplasmic cyclophilin, has been identified as the intracellular binding protein for the immunosuppressive drug cyclosporine A [2, 3]. Although CypA was initially shown to function primarily as an intracellular protein, recent studies have shown that it can be secreted by cells in response to inflammatory stimuli [4–8]. Elevated levels of extracellular CypA have been detected in the synovial fluid of patients with RA . CD147 is a cell surface glycoprotein that belongs to the immunoglobulin superfamily and was identified as the signaling receptor for extracellular CypA . CD147 is also known as EMMPRIN (extracellular matrix metalloproteinase inducer), and the expression of CD147 stimulates the production of matrix metalloproteinases (MMPs) . Increased expression of CD147 has been shown in patients with RA [12, 13]. Recent experimental finding suggests that CypA-CD147 interactions may be associated with the recruitment of leucocytes into the joint tissues . However, the precise process of interaction between CypA and its receptor CD147 in the development of RA remains unclear.
In the present study, we demonstrated that both CypA and CD147 are highly expressed in the joints of mice with collagen-induced arthritis (CIA). CypA was released from FLS, and increased CD147 expression in macrophages. These findings suggest that an interaction in the synovial joints between extracellular CypA and CD147 expressed by macrophages forms one of the critical mechanisms underlying the pathogenesis of RA.
Six-week-old male DBA/1J and C57BL/6N mice were purchased from Kyudo (Tosu, Japan). All the procedures involving experimental animals adhered to the law (No. 105) and notification (No. 6) of the Japanese Government, and were approved by the Laboratory Animal Care and Use Committee of Fukuoka University.
Induction of CIA in mice
Bovine type II collagen (CII) (Chondrex) was emulsified with an equal volume of complete Freund’s adjuvant (Chondrex) to give a final concentration of 1 mg/mL. DBA/1J mice were immunized intradermally at the base of the tail with 100 μg emulsified CII. Age-matched DBA/1J mice without CIA were employed as controls. The severity of arthritis was graded on a 0–4 scale, as previously described . Mice showing scale 4 in the severity of arthritis were supplied for the following experiments.
Isolation of FLS from CIA mice
Mouse FLS were isolated from the tarsus of the hind paws of CIA mice. After careful removal of the skin, joints were minced and digested for 2 h at 37°C in Dulbecco’s modified Eagle’s medium (DMEM) containing collagenase type 4 and DNase. After filtration through a 100-μm cell strainer, cell suspension was collected, centrifuged, resuspended, and cultured in DMEM supplemented with 10% fetal bovine serum (FBS). Cultured mouse FLS at 80–90% confluency in a dish (6 cm in diameter) were used for in vitro assays from passage 3 to 7.
Isolation of bone marrow-derived macrophages from mice
C57BL/6N mice were euthanized, and the femur and tibia of the hind legs were dissected. Bone marrow cavities were flushed with Minimum Essential Medium (MEM)-α. The bone marrow cells were cultured in MEM-α supplemented with 10% FBS, 20 ng/mL macrophage-colony stimulating factor (Sigma) for 5 days. Before use, bone marrow-derived macrophages were washed vigorously to remove nonadherent cells.
Immunohistochemistry of synovial tissues of control and CIA mice
For double immunofluorescence staining, the sections were incubated with a combination of rat anti-CD147 (AbD Serotec) and rabbit anti-CD11b antibodies. Cy3-conjugated anti-rat IgG and fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG antibodies were used as secondary antibodies. The sections of CIA mice were stained according to the method described above, except that the primary antibodies were omitted. Non-specific staining was almost null (negative control in Figure 2c). Images were captured using Confocal microscope (OLYMPUS).
Immunoblot analysis of CypA and CD147
Mice were anesthetized with sodium pentobarbital and decapitated. The ankle joints were frozen with liquid nitrogen, crushed, and lysed in RIPA buffer. Mouse FLS and macrophages were washed with PBS and lysed in RIPA buffer. Conditioned media from FLS were concentrated using an Amicon Ultra-50k and 10k centrifugal filters (Millipore). Denatured lysates and concentrated conditioned media were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were immunoblotted with anti-CypA, anti-CD147, anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (EPITOMICS) and anti-β-actin (IMGENEX) antibodies. Immunoblots were then exposed to peroxidase-conjugated secondary antibodies and visualized using a SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific).
Values are expressed as the mean ± S.E.M. Statistical analysis was performed using a Student’s t test or one way analysis of variance followed by Dunnett’s post hoc test. The differences between the means were considered to be significant at P < 0.05.
Results and discussion
Immunoblotting and immunohistochemical analysis showed that CypA was highly expressed in the joints of CIA mice compared with control mice (Figure 1a and b, respectively). This finding is consistent with a report of Damsker et al. ; these support the clinical evidence that elevated levels of extracellular CypA have been found in the synovial fluids of RA patients . To investigate whether FLS isolated from CIA mice secreted CypA, the conditioned media were obtained from FLS cultures and analyzed by western blotting (Figure 1c). FLS isolated from CIA mice were found to secrete CypA. CypA enhances the secretion of MMP-2 and MMP-9, cell invasion, and production of inflammatory cytokines in monocytes . These findings suggest that increased CypA in the synovial fluid may have a role in RA development.
When FLS were stimulated with lipopolysaccharide (LPS), CypA secretion was significantly increased to 170.5 ± 46.2% of control FLS (vehicle). LPS had no effect on the intracellular levels of CypA in FLS (Figure 1d). Toll-like receptor 4 (TLR4), a receptor for LPS, is highly expressed in the synovial tissue of RA patients . Mice defective in Tlr4 are protected from experimental arthritis , and TLR4 inhibitors ameliorate destructive arthritis in mice . Furthermore, endogenous TLR4 ligands, including heat shock proteins, tenascin-C, and S100 proteins, are expressed in the rheumatoid joints [20–22]. These findings suggest that endogenous TLR4 ligands may stimulate FLS to secrete CypA in CIA mice.
Bovine type II collagen
Dulbecco’s modified Eagle’s medium
Glyceraldehyde 3-phosphate dehydrogenase
Minimum Essential Medium
This work was supported in part by Grants-in-Aid for Scientific Research [to Y. K. (C) 22590255], Grants-in-Aid for Young Scientists [to T.N. (B) 23790311, to T.W. (B) 22790178] from the Japan Society for the Promotion of Science, the Japan Rheumatism Foundation and funds (No.:116007, No.:121502) from the Central Research Institute of Fukuoka University.
- Chang SK, Gu Z, Brenner MB: Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev. 2010, 233: 256-266. 10.1111/j.0105-2896.2009.00854.x.View ArticlePubMed
- Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW: Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984, 226: 544-547. 10.1126/science.6238408.View ArticlePubMed
- Takahashi N, Hayano T, Suzuki M: Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 1989, 337: 473-475. 10.1038/337473a0.View ArticlePubMed
- Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC: Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 2000, 87: 789-796. 10.1161/01.RES.87.9.789.View ArticlePubMed
- Kim SH, Lessner SM, Sakurai Y, Galis ZS: Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol. 2004, 164: 1567-1574. 10.1016/S0002-9440(10)63715-7.PubMed CentralView ArticlePubMed
- Satoh K, Nigro P, Matoba T, O’Dell MR, Cui Z, Shi X, Mohan A, Yan C, Abe J, Illig KA, Berk BC: Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med. 2009, 15: 649-656. 10.1038/nm.1958.PubMed CentralView ArticlePubMed
- Sherry B, Yarlett N, Strupp A, Cerami A: Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA. 1992, 89: 3511-3515. 10.1073/pnas.89.8.3511.PubMed CentralView ArticlePubMed
- Suzuki J, Jin ZG, Meoli DF, Matoba T, Berk BC: Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res. 2006, 98: 811-817. 10.1161/01.RES.0000216405.85080.a6.View ArticlePubMed
- Billich A, Winkler G, Aschauer H, Rot A, Peichl P: Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med. 1997, 185: 975-980. 10.1084/jem.185.5.975.PubMed CentralView ArticlePubMed
- Yurchenko V, Zybarth G, O’Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P: Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem. 2002, 277: 22959-22965. 10.1074/jbc.M201593200.View ArticlePubMed
- Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M: Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 2006, 56: 359-367. 10.1111/j.1440-1827.2006.01972.x.View ArticlePubMed
- Konttinen YT, Li TF, Mandelin J, Liljestrom M, Sorsa T, Santavirta S, Virtanen I: Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum. 2000, 43: 275-280. 10.1002/1529-0131(200002)43:2<275::AID-ANR6>3.0.CO;2-#.View ArticlePubMed
- Tomita T, Nakase T, Kaneko M, Shi K, Takahi K, Ochi T, Yoshikawa H: Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 2002, 46: 373-378. 10.1002/art.10050.View ArticlePubMed
- Damsker JM, Okwumabua I, Pushkarsky T, Arora K, Bukrinsky MI, Constant SL: Targeting the chemotactic function of CD147 reduces collagen-induced arthritis. Immunology. 2009, 126: 55-62. 10.1111/j.1365-2567.2008.02877.x.PubMed CentralView ArticlePubMed
- Nishioku T, Yamauchi A, Takata F, Watanabe T, Furusho K, Shuto H, Dohgu S, Kataoka Y: Disruption of the blood–brain barrier in collagen-induced arthritic mice. Neurosci Lett. 2010, 482: 208-211. 10.1016/j.neulet.2010.07.035.View ArticlePubMed
- Wang L, Wang CH, Jia JF, Ma XK, Li Y, Zhu HB, Tang H, Chen ZN, Zhu P: Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis. J Clin Immunol. 2010, 30: 24-33.View ArticlePubMed
- Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA, van den Berg WB: Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 2004, 50: 3856-3865. 10.1002/art.20678.View ArticlePubMed
- Lee EK, Kang SM, Paik DJ, Kim JM, Youn J: Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol. 2005, 17: 325-333. 10.1093/intimm/dxh212.View ArticlePubMed
- Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG, van den Berg WB: Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007, 56: 2957-2967. 10.1002/art.22848.View ArticlePubMed
- Grevers LC, de Vries TJ, Vogl T, Abdollahi-Roodsaz S, Sloetjes AW, Leenen PJ, Roth J, Everts V, van den Berg WB, van Lent PL: S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis. Arthritis Rheum. 2011, 63: 1365-1375.View ArticlePubMed
- Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G: Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009, 15: 774-780. 10.1038/nm.1987.View ArticlePubMed
- Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, Schreurs BW, van den Berg WB, Radstake TR: Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol. 2006, 176: 7021-7027.View ArticlePubMed
- Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZN: Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res Ther. 2005, 7: R1023-R1033. 10.1186/ar1778.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.